Tag - BDRX

Executive Moves

Biodexa appoints Fiona Sharp as CFO and company secretary

Biodexa Pharmaceuticals (NASDAQ: BDRX) has announced the promotion of Fiona Sharp to chief financial officer (CFO) and company secretary—in addition to her election to the board of directors—effective immediately. The...

January 5, 2026

Developments

FDA fast tracks Biodexa’s eRapa in FAP

Biodexa Pharmaceuticals (NASDAQ:BDRX) has announced that eRapa, a form of rapamycin being developed for the treatment of familial adenomatous polyposis (FAP), has been granted Fast Track Designation by the FDA...

February 10, 2025

Executive Moves

Biodexa names Dr. Gary A. Shangold as CMO

Biodexa Pharmaceuticals (NASDAQ:BDRX) has announced the appointment of Dr. Gary A. Shangold as chief medical officer (CMO), effective immediately. The company stated that Dr. Shangold brings extensive experience across...

January 22, 2025

Tag - BDRX

Biodexa appoints Fiona Sharp as CFO and company secretary

FDA fast tracks Biodexa’s eRapa in FAP

Biodexa names Dr. Gary A. Shangold as CMO

Subscribe